ARMAROLI, Annarita
 Distribuzione geografica
Continente #
NA - Nord America 1.532
EU - Europa 708
AS - Asia 169
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.415
Nazione #
US - Stati Uniti d'America 1.531
PL - Polonia 332
CN - Cina 111
DE - Germania 107
IT - Italia 87
UA - Ucraina 54
TR - Turchia 47
GB - Regno Unito 46
SE - Svezia 23
FI - Finlandia 21
RU - Federazione Russa 18
BE - Belgio 14
BR - Brasile 4
VN - Vietnam 4
ES - Italia 3
NL - Olanda 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
CL - Cile 1
EU - Europa 1
IN - India 1
IR - Iran 1
KZ - Kazakistan 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
SG - Singapore 1
Totale 2.415
Città #
Warsaw 332
Fairfield 246
Woodbridge 192
Chandler 147
Ann Arbor 140
Ashburn 102
Houston 88
Cambridge 82
Wilmington 78
Jacksonville 75
Seattle 74
Ferrara 42
Beijing 34
Izmir 29
New York 29
Milan 22
Bremen 21
Princeton 21
Falls Church 14
Nanjing 14
Shenyang 14
Boardman 13
Brussels 12
San Diego 12
Shanghai 11
Helsinki 8
Addison 6
Des Moines 6
Hebei 6
London 6
Changsha 5
Nanchang 5
Rome 5
Cagliari 4
Dearborn 4
São Paulo 4
Trebaseleghe 4
Dong Ket 3
Jinan 3
Ningbo 3
Redwood City 3
Tianjin 3
Zhengzhou 3
Jiaxing 2
Kunming 2
Lanzhou 2
Monmouth Junction 2
Orange 2
Phoenix 2
Redmond 2
Varazze 2
Waanrode 2
Almaty 1
Alpedrete 1
Andover 1
Barcelona 1
Birmingham 1
Bologna 1
Chicago 1
Edinburgh 1
George Town 1
Guarda Veneta 1
Haikou 1
Hangzhou 1
Hanoi 1
Kilburn 1
Los Angeles 1
Madrid 1
Manila 1
Modena 1
Mountain View 1
Norwalk 1
Palm Bay 1
Prescot 1
Reggio Nell'emilia 1
Sabz 1
San Mateo 1
Taizhou 1
Toronto 1
Wandsworth 1
Yellow Springs 1
Totale 1.972
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 319
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 292
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 146
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 143
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype 142
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 136
Paternal germline mosaicism in collagen VI related myopathies 132
Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping. 124
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: Implications for clinical trials 122
Cyclosporine a in Ullrich congenital muscular dystrophy: Long-term results 115
Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up 107
A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation 104
Huntington's disease-like presentation in Spinocerebellar ataxia type 12 102
Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia 101
Genetic counseling for women referred for advanced maternal age: a telegenetic approach 99
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 77
Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and Laminopathies 58
Hypospadias prevalence in the Emilia Romagna Region registry: Increasing or methodology? 44
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 35
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 22
TRANSCRIPTIONAL PROFILING IN DUCHENNE MUSCULAR DYSTROPHY REVEALED A PROFOUND DEREGULATION OF BOTH CIRCADIAN RHYTHM GENES AND GENES INVOLVED IN MUSCLE REGENERATIVE PROCESS AS POSSIBLE NEW DISEASE BIOMARKERS 16
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 15
TeleNEwCARe: An Italian case-control telegenetics study in patients with Hereditary NEuromuscular and CARdiac diseases 10
Totale 2.461
Categoria #
all - tutte 9.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019210 0 0 0 0 0 0 0 0 0 0 99 111
2019/2020570 76 25 29 80 42 63 55 47 44 50 36 23
2020/2021385 33 38 22 53 23 48 21 41 9 44 33 20
2021/2022260 19 24 5 9 8 21 31 11 12 23 29 68
2022/2023334 26 44 11 34 65 31 28 30 32 3 19 11
2023/2024136 15 16 17 4 10 51 4 14 4 1 0 0
Totale 2.461